What are the indications, pre‑operative preparation, procedural steps, and post‑operative care for permanent cardiac pacemaker implantation?

Permanent Cardiac Pacemaker Implantation

Indications for Permanent Pacemaker Implantation

Permanent pacemaker implantation is definitively indicated for third-degree or advanced second-degree AV block at any anatomic level when associated with symptomatic bradycardia, ventricular dysfunction, or documented asystole ≥3.0 seconds. 1

Class I Indications (Definite)

Acquired AV Block in Adults:

• Third-degree and advanced second-degree AV block with symptomatic bradycardia (including heart failure) or ventricular arrhythmias presumed due to AV block 1, 2
• Third-degree and advanced second-degree AV block requiring drugs that result in symptomatic bradycardia 1
• Third-degree and advanced second-degree AV block in awake, symptom-free patients with documented asystole ≥3.0 seconds or escape rate <40 bpm 1, 2
• Third-degree and advanced second-degree AV block with atrial fibrillation and pauses ≥5 seconds 1, 2
• Second-degree AV block with associated symptomatic bradycardia regardless of type or site 1, 2
• Post-catheter ablation of AV junction 1, 2
• Postoperative AV block not expected to resolve after cardiac surgery 1, 2

Sinus Node Dysfunction:

• Sinus node dysfunction with documented correlation of symptoms during age-inappropriate bradycardia 1, 2

Pediatric and Congenital Heart Disease:

• Advanced second- or third-degree AV block with symptomatic bradycardia, ventricular dysfunction, or low cardiac output 1, 2
• Postoperative advanced second- or third-degree AV block persisting ≥7 days after cardiac surgery 1, 2
• Congenital third-degree AV block with wide QRS escape rhythm, complex ventricular ectopy, or ventricular dysfunction 1, 2
• Congenital third-degree AV block in infants with ventricular rate <55 bpm or with congenital heart disease and ventricular rate <70 bpm 1, 2

Neuromuscular Diseases:

• Third-degree and advanced second-degree AV block associated with myotonic muscular dystrophy, Kearns-Sayre syndrome, or Erb dystrophy, with or without symptoms 1, 2

Class IIa Indications (Reasonable)

• Persistent third-degree AV block with escape rate >40 bpm in asymptomatic adults without cardiomegaly 2
• Asymptomatic second-degree AV block at intra- or infra-His levels found at electrophysiological study 2
• First- or second-degree AV block with symptoms similar to pacemaker syndrome or hemodynamic compromise 2
• Congenital third-degree AV block beyond first year of life with average heart rate <50 bpm or abrupt pauses 2-3 times the basic cycle length 1, 2

Class III Indications (Not Indicated)

• Asymptomatic type I second-degree AV block at the supra-His (AV node) level 2
• Transient AV conduction disturbances in absence of intraventricular conduction defects 3

Pre-operative Preparation

Before pacemaker implantation, exclude reversible causes of bradycardia including electrolyte abnormalities, drug toxicity, and assess for conditions requiring observation before permanent pacing. 1

Essential Pre-operative Assessment:

• Exclude reversible causes: Correct electrolyte abnormalities, assess for drug toxicity, evaluate for Lyme disease, hypervagotonia, perioperative hypothermia, or inflammation near AV conduction system 1
• Document indication: Confirm persistent bradycardia or conduction disorder with ECG documentation and symptom correlation 1
• Assess pacemaker dependency: Determine if patient has reliable escape rhythm or is completely pacemaker-dependent 4
• Evaluate comorbidities: Consider overall prognosis, presence of cardiac disease, cerebrovascular disease, and patient goals of care 3, 5
• Special populations: For post-cardiac surgery patients, wait 7 days to allow for potential recovery of conduction before permanent implantation 1, 2, 6

Timing Considerations:

For post-cardiac surgery patients, implant permanent pacemaker on postoperative day 7 to prevent unnecessary implantations while avoiding prolonged hospitalization. 6 Earlier implantation (≤6 days) is associated with higher rates of non-dependency at follow-up (56% not pacemaker-dependent), suggesting many recover AV conduction 6, 7.

For acute myocardial infarction, avoid early permanent pacing (<72 hours) to allow for potential recovery of conduction. 8

Procedural Steps

While the provided evidence focuses primarily on indications rather than detailed procedural technique, key procedural considerations include:

• Device selection: Choose between single-chamber and dual-chamber systems based on clinical indication, with dual-chamber pacing preferred for sinus node dysfunction to reduce atrial fibrillation and heart failure risk 5
• Lead placement: Transvenous approach is standard, with consideration of venous access and lead positioning 9
• Intraoperative testing: Ensure adequate sensing and capture thresholds 9

Post-operative Care

Critical care nurses must monitor for immediate complications including pneumothorax, hemothorax, cardiac perforation, and lead dislodgement in the early post-implantation period. 9

Immediate Post-operative Management:

• Complication surveillance: Monitor for pneumothorax, hemothorax, cardiac perforation, lead dislodgement, pocket hematoma, and infection (complications occur in 3-7% of cases) 8, 9
• Device interrogation: Verify appropriate sensing, pacing thresholds, and programmed settings 9, 4
• Early mobilization: Once stable, early mobilization reduces hospital stay, particularly important for post-cardiac surgery patients 7

Long-term Follow-up:

Approximately 37-44% of patients receiving pacemakers after cardiac surgery will not be pacemaker-dependent at long-term follow-up, necessitating regular device interrogation. 6, 7

• Regular device checks: Monitor for pacemaker dependency, battery status, and lead function 9
• Assess for recovery: Particularly in post-surgical patients, test for return of intrinsic conduction at follow-up visits 6, 7
• Quality of life monitoring: Pacemaker implantation substantially improves quality of life in patients with appropriate indications 5

Risk Factors for Permanent Dependency:

• Third-degree AV block as indication (versus sinus node dysfunction) 6
• Preoperative left bundle branch block 7
• Pulmonary hypertension 10
• Aortic valve replacement 7

Shared Decision-Making

Clinicians and patients must engage in shared decision-making that incorporates not only evidence-based indications but also patient goals of care, preferences, and values. 5

Key Discussion Points:

• Procedural risks: Short-term complications (3-7%), long-term lead management issues, and potential need for future revisions 5, 8
• Alternative therapies: When applicable, discuss options such as radiofrequency catheter ablation for bradycardia-tachycardia syndrome 1, 2
• Prognosis considerations: In patients with significant comorbidities where pacing is unlikely to provide meaningful benefit, or when patient goals strongly preclude therapy, pacemaker implantation should not be performed 5
• End-of-life planning: Discuss potential future considerations including device deactivation 5